Cervarix - Preventing cervical cancer and other diseases related to HPV

Journal article

Human papillomavirus (HPV) is the pathological agent required for the development and progression of precancerous lesions in the cervical epithelium. Just two HPV types account for around 70% of all cases of cervical cancer. Therefore, there is a clear rationale for the development of prophylactic vaccines that protect against infection by these oncogenic HPV strains in order that the substantial burden of cervical cancer can be reduced. Two vaccines have been developed which comprise type-sp...

Expand abstract

Authors: Chambers, S; Kassianos, G; Brown, P; Gaw, A; Kirby, M

• Journal: Drugs in Context
• Volume: 4
• Issue: 1
• Pages: 59-70
• Publication date: 2008-01-01
• EISSN: 1740-4398
• ISSN: 1745-1981
• Language: English
• Keywords: Human papillomavirus; Cervarix; Cervical intraepithelial neoplasia (CIN); HPV; Cervical cancer